All Legal articles – Page 5
View all stories with this category.
-
BusinessUS court denies Amgen appeal over Pfizer biosimilar
Amgen has lost its bid to compel Pfizer to divulge information about its version of anaemia drug Epogen
-
Business
Celgene pays $280m to settle off-label marketing lawsuit
Whistleblower case relating to cancer prescriptions
-
Business
Lilly wins chemotherapy patent appeal
Firm also settles with generic manufacturers of erectile dysfunction drug Cialis
-
Business
Mallinckrodt settles US opioid lawsuit
Firm will pay $35m over allegations it failed to report suspicious orders of controlled substances
-
Business
EU to investigate Merck KGaA’s merger with Sigma–Aldrich
Commission says Merck failed to disclose a crucial research project
-
Business
Silence Therapeutics and Alnylam in patent dispute
Suit alleges competitors need to license Silence patents relating to their drug cantidates
-
Business
GM corn growers win US lawsuit against Syngenta
Kansas jury awards over $217m damages to farmers in the first of eight trials
-
Business
FDA asks Endo to take pain drug off market
Request part of larger strategy to address opioid misuse in the US
-
Business
US supreme court limits patent rights
Biotech industry is concerned that ruling will hit small companies
-
Business
Dow will face dioxin suit
US appeals court rules property owners have a valid case over soil contamination
-
Business
European Commission to investigate excessive drug pricing
Inquiry covers claims that Aspen Pharma’s price rises on five cancer treatments were unjustified
-
Business
GE accused of exposing workers to toxic chemicals
Canadian union says dangerous compounds were used without proper worker protection
-
Business
Seattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
News
Legal battles stall US biosimilars
Unclear legislation and lack of regulatory guidance means companies are turning to the courts
-
Business
J&J fights talc cancer claims
Firm has lost several court cases linking talc to ovarian cancer, but vows to appeal
-
Business
India probes Roche over biosimilars
Mylan and Biocon claim Roche abused its market dominance to quash generic breast cancer antibodies
-
Business
Brexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
Business
US university sues Dow over pollution
Three hazardous chemicals have infiltrated campus groundwater, and the school wants Dow and others to pay for clean-up
-
Business
Lilly loses arbitration over Canadian patents
Firm had sought recompense under the Nafta trade agreement
-
Business
EU recommends withdrawing drugs approved on unreliable data
Indian firm Micro Therapeutic Research Labs accused of misrepresenting clinical data and documentation deficiencies
